文献速递肿瘤 PET/CT甲状腺核医学

68Ga-DOTATATE与18F-FDG PET/CT在Castleman病中的表现

68Ga-DOTATATE and 18F-FDG in Castleman Disease.
PubMed 文献 · Clin Nucl Med · 2020-01-01

一例35岁女性直肠神经内分泌肿瘤(Ki-67<2%)术后CT发现纵隔肿块,行68Ga-DOTATATE PET/CT再分期显示盆腔淋巴结和纵隔肿块摄取。因病灶SUV差异及临床表现怀疑淋巴瘤,追加18F-FDG PET/CT示纵隔肿块糖代谢增高而盆腔淋巴结无高代谢,活检免疫组化符合Castleman病。

要点

  • 神经内分泌肿瘤患者纵隔肿块在68Ga-DOTATATE PET/CT上可因生长抑素受体表达而摄取。
  • Castleman病纵隔肿块可表现为18F-FDG高代谢而68Ga-DOTATATE摄取,易误判为神经内分泌肿瘤转移。
  • 当病灶SUV与临床表现不符时,追加18F-FDG PET/CT及活检有助于鉴别诊断。

核心结论

  • Castleman病纵隔肿块可同时表现为68Ga-DOTATATE摄取和18F-FDG高代谢,需与神经内分泌肿瘤转移鉴别。

研究设计与样本

  • 单例病例报告:35岁女性直肠神经内分泌肿瘤(Ki-67<2%)术后CT发现纵隔肿块,行68Ga-DOTATATE PET/CT再分期。

主要发现

  • 68Ga-DOTATATE PET/CT显示盆腔淋巴结和纵隔肿块摄取。
  • 因病灶SUV差异及临床表现怀疑淋巴瘤,追加18F-FDG PET/CT示纵隔肿块糖代谢增高而盆腔淋巴结无高代谢。
  • 纵隔肿块经胸穿刺活检示非典型大细胞淋巴样增殖,免疫组化符合Castleman病。

临床怎么用

  • 神经内分泌肿瘤患者出现不典型纵隔肿块时,应结合68Ga-DOTATATE与18F-FDG PET/CT表现及活检综合判断。

局限性

  • 单例病例报告,结论不能推广至所有Castleman病或神经内分泌肿瘤患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 35-year-old woman with rectal neuroendocrine tumor, Ki-67 proliferation index less than 2%, and a mediastinal mass on CT postoperatively was referred for restaging with PET/CT Ga-DOTATATE. The examination showed uptake on the pelvic lymph node and mediastinal mass. Because of differences in lesions' SUVs and clinical presentation, the hypothesis of lymphoma for the mediastinal mass was raised, and F-FDG PET/CT was performed, which showed glycolytic hypermetabolism in the mediastinal mass and absence of hypermetabolism in pelvic lymph nodes. Transthoracic biopsy of the mass revealed atypical large-cell lymphoid proliferation, and immunohistochemistry study was compatible with Castleman disease.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Verçosa AFA, Flamini MEDM, Loureiro LVM, et al. 68Ga-DOTATATE and 18F-FDG in Castleman Disease. Clin Nucl Med. 2020. PMID: 32969902. doi:10.1097/RLU.0000000000003277

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。